FAQs for Opioid Use Disorder Prescribing and Dispensing in the COVID-19 EmergencyIn response to the Novel Coronavirus Disease (COVID-19) pandemic, SAMHSA is providing answers to Frequently Asked Questions regarding the provision of methadone and buprenorphine for the treatment of Opioid Use Disorder for new and existing patients. |
viernes, 20 de marzo de 2020
FAQs for Opioid Use Disorder Prescribing and Dispensing in the COVID-19 Emergency
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario